Engineered Bacillus Calmette-Guérin Mediated Immunotherapy of Triple-Negative Breast Cancer
ACS Nano · 2026
DOI: 10.1021/acsnano.5c22491 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Weinan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Triple Negative Breast Neoplasms, Mycobacterium bovis, BCG Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: University Natural Science Research Project of Anhui Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei, 230032, P. R. China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, 230601, P. R. China.
ORCID-Profile: Wanni Wang, Haisheng Qian
Förderung
- University Natural Science Research Project of Anhui Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Shen, H., Jiang, Y., Huang, X., Liu, L., Fang, S., Wu, Y., Chu, Z., Wang, W., & Qian, H. (2026). Engineered Bacillus Calmette-Guérin Mediated Immunotherapy of Triple-Negative Breast Cancer. ACS Nano. https://doi.org/10.1021/acsnano.5c22491
Vancouver
Zhang W, Shen H, Jiang Y, Huang X, Liu L, Fang S, et al. Engineered Bacillus Calmette-Guérin Mediated Immunotherapy of Triple-Negative Breast Cancer. ACS Nano. 2026. doi:10.1021/acsnano.5c22491
BibTeX
@article{Zhang2026,
author = {Zhang, Weinan and Shen, Hui and Jiang, Yechun and Huang, Xianyu and Liu, Litao and Fang, Shu and Wu, Yayun and Chu, Zhaoyou and Wang, Wanni and Qian, Haisheng},
title = {Engineered Bacillus Calmette-Guérin Mediated Immunotherapy of Triple-Negative Breast Cancer},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.5c22491}
}
EUVIMED